Skip to main content

Table 1 Numbers of animals used for analysis of behavioural tasks and of electrophysiological recording of fEPSPs, depending on age, genotype and treatment given

From: Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model

Age Genotype Treatment Behaviour Electrophysiology
6 months WT Saline N = 14 N = 6
6 months WT D-Ala2GIP N = 14 N = 6
6 months APP/PS1 Saline N = 12 N = 8
6 months APP/PS1 D-Ala2GIP N = 12 N = 8
12 months WT Saline N = 11 N = 7
12 months WT D-Ala2GIP N = 12 N = 7
12 months APP/PS1 Saline N = 11 N = 7
12 months APP/PS1 D-Ala2GIP N = 11 N = 6
  1. fEPSP, field excitatory post-synaptic potential; GIP, glucose-dependent insulinotropic polypeptide; N, number.